Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Hauser

Showing results (101-110 of 266) with videos related to

Pageof 27
Sort By:
The International Journal of Neuroscience|January 20, 2011
Long-term, open-label study of once-daily ropinirole prolonged release in early Parkinson's diseaseRobert A Hauser, Heinz Reichmann, Mark Lew, et al.
Clinical Neuropharmacology|June 15, 2006
The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin statusTheresa A Zesiewicz, Lynn Wecker, Kelly L Sullivan, et al.
Parkinsonism & Related Disorders|July 15, 2005
Levetiracetam for the treatment of generalized dystoniaKelly L Sullivan, Robert A Hauser, Elan D Louis, et al.
Clinical Neuropharmacology|June 23, 2016
Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic HypotensionRobert A Hauser, Stephane Heritier, Gerald J Rowse, et al.
Journal of Medical Economics|December 29, 2015
Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial dataClément François, Robert A Hauser, Samuel Aballéa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2004
Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled studyCheryl H Waters, Kapil D Sethi, Robert A Hauser, et al.
The Annals of Pharmacotherapy|July 5, 2018
Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized TrialsJack J Chen, Yi Han, Jonathan Tang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2008
Transplanted dopaminergic neurons develop PD pathologic changes: a second case reportJeffrey H Kordower, Yaping Chu, Robert A Hauser, et al.
The American Journal of Cardiology|February 5, 2017
Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic HypotensionWilliam B White, Robert A Hauser, Gerald J Rowse, et al.
Nature Medicine|April 9, 2008
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's diseaseJeffrey H Kordower, Yaping Chu, Robert A Hauser, et al.
Pageof 27

Showing results (101-110 of 266) with videos related to

Sort By:
Pageof 27
The International Journal of Neuroscience|January 20, 2011
Long-term, open-label study of once-daily ropinirole prolonged release in early Parkinson's diseaseRobert A Hauser, Heinz Reichmann, Mark Lew, et al.
Clinical Neuropharmacology|June 15, 2006
The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin statusTheresa A Zesiewicz, Lynn Wecker, Kelly L Sullivan, et al.
Parkinsonism & Related Disorders|July 15, 2005
Levetiracetam for the treatment of generalized dystoniaKelly L Sullivan, Robert A Hauser, Elan D Louis, et al.
Clinical Neuropharmacology|June 23, 2016
Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic HypotensionRobert A Hauser, Stephane Heritier, Gerald J Rowse, et al.
Journal of Medical Economics|December 29, 2015
Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial dataClément François, Robert A Hauser, Samuel Aballéa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2004
Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled studyCheryl H Waters, Kapil D Sethi, Robert A Hauser, et al.
The Annals of Pharmacotherapy|July 5, 2018
Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized TrialsJack J Chen, Yi Han, Jonathan Tang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2008
Transplanted dopaminergic neurons develop PD pathologic changes: a second case reportJeffrey H Kordower, Yaping Chu, Robert A Hauser, et al.
The American Journal of Cardiology|February 5, 2017
Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic HypotensionWilliam B White, Robert A Hauser, Gerald J Rowse, et al.
Nature Medicine|April 9, 2008
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's diseaseJeffrey H Kordower, Yaping Chu, Robert A Hauser, et al.
Pageof 27